Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

SHE:002393 Revenue

Tianjin Lisheng Pharmaceutical had revenue of 332.28M CNY in the quarter ending March 31, 2026, a decrease of -10.16%. This brings the company's revenue in the last twelve months to 1.35B, up 0.99% year-over-year. In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B with 4.18% growth.

• Revenue (ttm): 1.35B
• Revenue Growth: +0.99%
• P/S Ratio: 3.44
• Revenue / Employee: 843.90K
• Employees: 1,605
• Market Cap: 4.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.39B	55.86M	4.18%
Dec 31, 2024	1.34B	183.12M	15.88%
Dec 31, 2023	1.15B	6.44M	0.56%
Jan 1, 2023	1.15B	54.65M	5.00%
Jan 1, 2022	1.09B	-48.90M	-4.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error